Crossmark Global Holdings’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.39M Buy
13,258
+137
+1% +$33.7K 0.04% 333
2026
Q2
$2.45M Buy
13,121
+275
+2% +$50.6K 0.03% 400
2026
Q1
$2.42M Buy
12,846
+1,957
+18% +$412K 0.04% 389
2025
Q4
$2.16M Sell
10,889
-2,040
-16% -$412K 0.03% 418
2025
Q3
$2.63M Sell
12,929
-48
-0.4% -$8.52K 0.04% 373
2025
Q2
$2.28M Sell
12,977
-2,790
-18% -$420K 0.04% 398
2025
Q1
$2.12M Buy
15,767
+7,036
+81% +$927K 0.04% 400
2024
Q4
$1.1M Buy
8,731
+2,544
+41% +$378K 0.02% 561
2024
Q3
$1.03M Buy
6,187
+1,600
+35% +$242K 0.02% 603
2024
Q2
$610K Buy
+4,587
New +$552K 0.01% 748

Other funds holding THC

Crossmark Global Holdings's THC Position: Q3 2026 in Review

Crossmark Global Holdings increased its Tenet Healthcare (THC) stake by 1% in Q3 2026, buying an estimated $33.7K and bringing the position to 13,258 shares worth $3.39M. The position accounts for 0.04% of the portfolio, ranked #333.

Crossmark Global Holdings first reported a position in THC in Q2 2024 and has held it in 10 quarters since. 124 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Crossmark Global Holdings held 13,258 shares of Tenet Healthcare worth $3.39M as of Q3 2026.
  • Crossmark Global Holdings bought 137 Tenet Healthcare shares in Q3 2026, an estimated $33.7K.
  • Tenet Healthcare made up 0.04% of Crossmark Global Holdings's portfolio in Q3 2026, its #333 holding.
  • Crossmark Global Holdings first reported a position in Tenet Healthcare in Q2 2024 and has held it in 10 quarters since.
  • 124 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.